Octreotide Reduces Vitreous Hemorrhage and Loss of Visual Acuity Risk in Patients with High-Risk Proliferative Diabetic Retinopathy

In diabetics with high-risk proliferative retinopathy after full scatter laser coagulation, octreotide reduced the number of vitreous hemorrhages, preserving visual acuity.